PBH(Prestige Consumer Healthcare Inc.) · 财务报表

PBH(Prestige Consumer Healthcare Inc.) 的财务报表:医疗保健,特药与仿制药。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2022-03-31FY 截至 2023-03-31FY 截至 2024-03-31FY 截至 2025-03-31FY 截至 2026-03-31
营业收入$1.09B$1.13B$1.13B$1.14B$1.09B
毛利润$620.65M$625.29M$624.45M$634.46M$595.58M
营业利润$329.92M−$22.41M$342.43M$336.77M$309.41M
净利润$205.38M−$82.31M$209.34M$214.60M$190.30M
经营现金流$259.92M$229.72M$248.93M$251.51M$257.63M
自由现金流$250.28M$221.93M$239.38M$243.29M$246.45M
摊薄每股收益$4.04$-1.65$4.17$4.29$3.91

Prestige Consumer Healthcare Inc. PBH